Rational drug design for Alzheimer's disease: from approved therapies to next-generation clinical candidates and AI-guided innovation
{{output}}
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by multifactorial pathology, including amyloid-β (Aβ) aggregation, tau hyperphosphorylation, oxidative stress, neuroinflammation, and synaptic dysfunction. Despite extensive ... ...
